Expression of L-type amino acid transporter 1 (LAT1) and 4F2 heavy chain (4F2hc) in oral squamous cell carcinoma and its precusor lesions

Anticancer Research

Volumn 24, Issue 3 A, 2004, Pages 1671-1675

  Kim, Do Kyung ^a   Ahn, Sang Gun ^a   Park, Joo Cheol ^a   Kanai, Yoshikatsu ^b   Endou, Hitoshi ^b   Yoon, Jung Hoon ^a  

^a Chosun University   (South Korea)

^b KYORIN UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

4F2hc; LAT1; Oral squamous cell carcinoma

Indexed keywords

AMINO ACID TRANSPORTER 1; AMINO ACID TRANSPORTER 4F2 HEAVY CHAIN; PARAFFIN; PROTEIN SUBUNIT; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER INHIBITION; CARCINOGENESIS; CONTROLLED STUDY; DYSPLASIA; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MOUTH CARCINOMA; MOUTH MUCOSA; PRECANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; ANTIGENS, CD98 HEAVY CHAIN; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; LARGE NEUTRAL AMINO ACID-TRANSPORTER 1; MALE; MIDDLE AGED; MOUTH MUCOSA; MOUTH NEOPLASMS; PARAFFIN EMBEDDING; PRECANCEROUS CONDITIONS;

EID: 3242699744     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Ohkame H, Masuda H, Ishii Y and Kanai Y: Expression of L-type amino acid transporter 1 (LAT1) and 4F2 heavy chain (4F2hc) in liver tumor lesions of rat models. J Surg Oncol 78: 265-271, 2001.
2. Medina MA, Sanchez-Jimenez F, Marquez J, Rodriguez Quesada A and Nunez de Castro I: Relevance of glutamine metabolism to tumor cell growth. Mol Cell Biochem 113: 1-15, 1992.
3. Wasa M, Bode BP, Abcouwer SF, Collins CL, Tanabe KK and Souba WW: Glutamine as a regulator of DNA and protein biosynthesis in human solid tumor cell lines. Ann Surg 224: 189-197, 1996.
4. Christensen HN: Role of amino acid transport and countertransport in nutrition and metabolism. Physiol Rev 70: 43-77, 1990.
5. Oxender DL and Christensen HN: Evidence for two types of mediation of neutral amino acid transport in Ehrlich cells. Nature 197: 765-767, 1963.
6. Kanai Y, Segawa H, Miyamoto K, Uchino H, Takeda E and Endou H: Expression cloning and characterization of a transporter for large neutral amino acids activated by the heavy chain of 4F2 antigen (CD98). J Biol Chem 273: 23629-23632, 1998.
7. Yanagida O, Kanai Y, Chairoungdua A, Kim DK, Segawa H, Nii T, Cha SH, Matsuo H, Fukushima J, Fukasawa Y, Tani Y, Taketani Y, Uchino H, Kim YJ, Inatomi J, Okayasu I, Miyamoto K, Takeda E, Goya T and Endou H: Human L-type amino acid transporter 1 (LAT1): characterization of function and expression in tumor cell lines. Biochim Biophys Acta 1514: 291-302, 2001.
8. Sang J, Lim YP, Panzica M, Finch P and Thompson NL: TA1, a highly conserved oncofetal complementary DNA from rat hepatoma, encodes an integral membrane protein associated with liver development, carcinogenesis, and cell activation. Cancer Res 55: 1152-1159, 1995.
9. Wolf DA, Wang S, Panzica MA, Bassily NH and Thompson NL: Expression of a highly conserved oncofetal gene, TA1/E16, in human colon carcinoma and other primary cancers: homology to Schistosoma mansoni amino acid permease and Caenorhabditis elegans gene products. Cancer Res 56: 5012-5022, 1996.
10. Nakamura E, Sato M, Yang H, Miyagawa F, Harasaki M, Tomita K, Matsuoka S, Noma A, Iwai K and Minato N: 4F2 (CD98) heavy chain is associated covalently with an amino acid transporter and controls intracellular trafficking and membrane topology of 4F2 heterodimer. J Biol Chem 274: 3009-3016, 1999.
11. Prasad PD, Wang H, Huang W, Kekuda R, Rajan DP, Leibach FH and Ganapathy V: Human LAT1, a subunit of system L amino acid transporter: molecular cloning and transport function. Biochem Biophys Res Commun 255: 283-288, 1999.
12. Haynes BF, Hemler ME, Mann DL, Eisenbarth GS, Shelhamer J, Mostowski HS, Thomas CA, Strominger JL and Fauci AS: Characterization of a monoclonal antibody (4F2) that binds to human monocytes and to a subset of activated lymphocytes. J Immunol 126: 1409-1414, 1981.
13. Hemler ME and Strominger JL: Characterization of antigen recognized by the monoclonal antibody (4F2): different molecular forms on human T and B lymphoblastoid cell lines. J Immunol 129: 623-628, 1982.
14. Rintoul RC, Buttery RC, Mackinnon AC, Wong WS, Mosher D, Haslett C and Sethi T: Cross-linking CD98 promotes integrin-like signaling and anchorage-independent growth. Mol Biol Cell 13: 2841-2852, 2002.
15. Singh RK and Siegal GP: Amino acid transport systems modulate human tumor cell growth and invasion: a working hypothesis. Med Hypotheses 44: 195-201, 1995.
16. Williams HK, Springall DR, Bhatnagar M and Polak JM: Immunocytochemical detection of ornithine decarboxylase (ODC) in paraffin-embedded tissues as a possible prognostic indicator for oral lesions. J Oral Pathol Med 24: 322-328, 1995.
17. Sutinen M, Kainulainen T, Hurskainen T, Vesterlund E, Alexander JP, Overall CM, Sorsa T and Salo T: Expression of matrix metalloproteinases (MMP-1 and -2) and their inhibitors (TIMP-1, -2 and -3) in oral lichen planus, dysplasia, squamous cell carcinoma and lymph node metastasis. Br J Cancer 77: 2239-2245, 1998.
18. Fenczik CA, Sethi T, Ramos JW, Hughes PE and Ginsberg MH: Complementation of dominant suppression implicates CD98 in integrin activation. Nature 390: 81-85, 1997.
19. Kim DK, Kanai Y, Choi HW, Tangtrongsup S, Chairoungdua A, Babu E, Tachampa K, Anzai N, Iribe Y and Endou H: Characterization of the system L amino acid transporter in T24 human bladder carcinoma cells. Biochim Biophys Acta 1565: 112-121, 2002.